Hepatitis D virus seroprevalence in HBsAg positive patients attending a tertiary care hospital in Northeast India


  • Kongbrailatpam Tharbendra Sharma Department of Microbiology, Regional Institute of Medical Sciences, Imphal, Manipur, India
  • S. Praveen Department of Microbiology, Regional Institute of Medical Sciences, Imphal, Manipur, India
  • Krossnunpuii . Department of Microbiology, Regional Institute of Medical Sciences, Imphal, Manipur, India
  • Swarnatrisha Saha Department of Microbiology, Regional Institute of Medical Sciences, Imphal, Manipur, India
  • Batkupar Syiemiong Department of Microbiology, Regional Institute of Medical Sciences, Imphal, Manipur, India




Hepatitis D virus, HBsAg, ELISA, IgM, IgG


Background: Hepatitis D virus (HDV) infection is present worldwide. Around 18 million people are estimated to be infected with HDV and can infect individuals with active HBV infection and cause severe liver disease. There is lack of data on the prevalence of HDV infection in the state and also in the region. The aim of the study was to determine the seroprevalence of HDV in HBsAg positive patients attending Regional Institute of Medical Sciences Hospital, Imphal, Manipur, India.

Methods: This study was carried out in a tertiary care hospital (Regional Institute of Medical Sciences, Imphal).The study was done for a period of 2 years from September 2016 to August 2018. A total of 119 HBsAg ELISA positive cases were included in the study.

Results: Out of 119 HBsAg positive cases, 5 cases were positive for hepatitis D antibodies, of which 3 were positive for anti-Hepatitis D virus IgM and 2 were positive for anti-Hepatitis D virus IgG. Seroprevalence of HDV infection was found to be 4.2%.

Conclusions: Seroprevalence of HDV infection was found to be 4.2% which is higher than the finding in some of the recent studies in the country.


Rizzetto M, Canese MG, Aricò S, Crivelli O, Trepo C, Bonino F, et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977;18(12):997-1003.

Gerin JL, Casey JL, Purcell RH. Hepatitis delta virus. In: Hollinger FB, Purcell RH, Gerin JL, eds. Viral hepatitis. Philadelphia: Lippincott Williams & Wilkins; 2002: 169-182.

Radjef N, Gordien E, Ivaniushina V, Gault E, Anaïs P, Drugan T, et al. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol. 2004;78(5):2537-44.

Shakil AO, Hadziyannis S, Hoofnagle JH, Bisceglie AM, Gerin JL, Casey JL. Geographic distribution and genetic variability of hepatitis delta virus genotype I. Virology. 1997;234(1):160-7.

Abbas Z, Jafri W, Raza S. Hepatitis D: Scenario in the Asia-Pacific region. World J Gastroenterol. 2010;16(5):554-62.

Ponzetto A, Hoyer BH, Popper H, Engle R, Purcell RH, Gerin JL. Titration of the infectivity of hepatitis D virus in chimpanzees. J Infect Dis. 1987;155(1):72-8.

Tahaei SM, Mohebbi SR, Azimzadeh P, Behelgardi A, Sanati A, Mohammadi P, et al. Prevalence of hepatitis D virus in hepatitis B virus infected patients referred to Taleghani hospital, Tehran, Iran. Gastroenterol Hepatol Bed Bench. 2014;7(3):144-50.

Noureddin M, Gish R. Hepatitis delta: epidemiology, diagnosis and management 36 years after discovery. Curr Gastroenterol Rep. 2014;16(1):365.

Farci P, Niro GA. Clinical features of hepatitis D. Semin Liver Dis. 2012;32(3):228-36.

Kew MC. Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an update. J Viral Hepat. 2013;20(3):149-57.

Yurdaydin C. Treatment of chronic delta hepatitis. Semin Liver Dis 2012;32:237-44.

Niro GA, Ciancio A, Tillman HL, Lagget M, Olivero A, Perri F, et al. Lamivudine therapy in chronic delta hepatitis: a multicentre randomized controlled pilot study. Aliment Pharmacol Ther. 2005;22:227-32.

Garripoli A, Marco V, Cozzolongo R, Costa C, Smedile A, Fabiano A, et al. Ribavirin treatment for chronic hepatitis D: a pilot study. Liver. 1994;14(3):154-7.

Yurdaydin C, Bozkaya H, Gürel S, Tillmann HL, Aslan N, Okçu-Heper A, et al. Famciclovir treatment of chronic delta hepatitis. J Hepatol. 2002;37(2):266-71.

Lau DT, Doo E, Park Y, Kleiner DE, Schmid P, Kuhns MC, et al. Lamivudine for chronic delta hepatitis. Hepatology. 1999;30(2):546-9.

Wedemeyer H, Yurdaydìn C, Dalekos GN, Erhardt A, Çakaloğlu Y, Değertekin H, et al. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med. 2011 Jan 27;364(4):322-31.

Dienstag L. Chronic hepatitis. In: Kasper L, Hauser L, Jameson L, Fauci S, eds. Harrison’s Principles of Internal Medicine. 19th ed. New York: McGraw Hill; 2015: 2040.

Shah L, Mulla SA. Prevalence of Hepatitis D virus in South Gujarat. Nat J Med Res. 2012;2(2):117-9.

Murhekar MV, Murhekar KM, Arankalle VA, Sehgal SC. Hepatitis delta virus infection among the tribes of the Andaman and Nicobar Islands, India. Trans R Soc Trop Med Hyg. 2005;99(7):483-4.

Banker DD, Desai P, Brawner TA, Decker RH. Hepatitis delta virus infection in Bombay. Trans R Soc Trop Med Hyg. 1992;86(4):424-5.

Amarapurkar DN, Vishwanath N, Kumar A, Shankaran S, Murti P, Kalro RH, et al. Prevalence of delta virus infection in high risk population and hepatitis B virus related liver diseases. Indian J Gastroenterol. 1992;11(1):11-2.

Chakraborty P, Kailash U, Jain A, Goyal R, Gupta RK, Das BC, et al. Seroprevalence of hepatitis D virus in patients with hepatitis B virus-related liver diseases. Indian J Med Res. 2005;122(3):254-7.

Saravanan S, Velu V, Kumarasamy N, Shankar EM, Nandakumar S, Murugavel KG, et al. Seroprevalence of hepatitis delta virus infection among subjects with underlying hepatic diseases in Chennai, southern India. Trans R Soc Trop Med Hyg. 2008;102(8):793-6.

Chakraborty C, Ghosh KJ, Chakraborty S. Prevalence of hepatitis D among the cases of hepatitis B infection in a tertiary care centre in Eastern India. Indian J Basic Appl Med Res. 2015;4 (4):195-9.

Patel FM, Goswami PN. Presence of acute hepatitis D infection in HBsAg positive cancer patients: A preliminary study from west Gujarat. Indian J Med Res. 2016;143(6):798-800.

Bhattacharyya S, Dalal BS, Lahiri A. Hepatitis D infectivity profile among hepatitis B infected hospitalised patients in Calcutta. Indian J Public Health. 1998;42(4):108-12.

Gheorghe L, Csiki IE, Iacob S, Gheorghe C, Trifan A, Grigorescu M, et al. Hepatitis Delta Virus Infection in Romania: Prevalence and Risk Factors. J Gastrointestin Liver Dis. 2015;24(4):413-21.






Original Research Articles